Agilent Technologies (A)
Health Care · Analytical instruments and lab equipment
A diversified healthcare and life sciences company providing analytical instruments, software, and services for pharmaceutical, chemical, and clinical diagnostics laboratories worldwide.
What Agilent Technologies does
Agilent Technologies is a supplier of analytical instruments, consumables, software, and services used in pharmaceutical, chemical, environmental, and clinical diagnostics applications. The company operates through segments that provide mass spectrometers, chromatography systems, molecular instruments, and associated software and consumables. Agilent generates revenue from both product sales and services/support, with a 19.55% net profit margin and demonstrated 9.11% year-over-year revenue growth as of mid-2026.
Themes: ["Pharmaceutical R&D instrumentation"]
Fundamentals
- Price$133.59 as of 2026-07-09 close
- Market cap$37.0B as of 2026-07-10
- 1-year return+10.1% as of 2026-07-09 close
- P/E26.18 as of 2026-07-10
- Net margin+19.6% as of 2026-07-10
- Gross margin+52.9% as of 2026-07-10
- ROE+20.8% as of 2026-07-10
- Debt / equity0.47 as of 2026-07-10
- Revenue growth (YoY)+9.1% as of 2026-07-10
- Revenue CAGR (3y)+0.5% SEC XBRL
- Beta1.24 as of 2026-07-10
Dividend: yield +0.8%; 5-year non-decreasing per-share dividend streak (SEC XBRL).
Key risks (from latest filing)
["Dependence on pharmaceutical and chemical industry spending for capital equipment purchases, which can decline during economic downturns or reduced R&D budgets."]
Competitors & peers
Fundamentals: Finnhub, as of 2026-07-10. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-09.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date.